Collectively, these studies suggest that GZD824 negatively regulated the survival and proliferation of pre-B ALL cells by inhibiting the SRC kinase and PI3K/AKT signaling pathways (Figure 7). Here, AKT1 is linked to acute lymphoblastic leukemia.